2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$6.58-$0.06 (-0.90%)
Price as of Jun 03, 2026 4:10 PM EDT- $274.5MMarket Cap
- -19.42%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$6.58-$0.06 (-0.90%)
TRDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.64 | ||
Change | -$0.27 (-3.91%) | ||
Open | $6.80 | ||
High | $6.80 | ||
Low | $6.50 | ||
Previous Close | $6.91 | ||
Volume | 299,078 | ||
30-Day Average Volume | 695,329 | ||
1-Week Change | -0.90% | ||
1-Month Change | -54.21% | ||
1-Year Change | -19.42% | ||
3-Year Change | -45.62% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 38.8M | ||
Total Assets | $335.5M | ||
Market Cap | $274.5M | ||
Enterprise Value | $198.0M | ||
Period: QTR TTM FY | |||
Revenue | $875,000.00 | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$41.7M | ||
EBIT | -$39.7M | ||
EBITDA | -$38.9M | ||
Net Working Capital | $247.7M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | 226 | ||
P/B | 1 | ||
P/E | -7 | ||
PEG | 8 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue